Atlas Trials

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Clinical trial NCT01484015 · COMPLETED

Trial details

NCT number
NCT01484015
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt LymphomaAdult Diffuse Large Cell LymphomaAdult Diffuse Mixed Cell LymphomaAdult Diffuse Small Cleaved Cell LymphomaAdult Hodgkin LymphomaAdult Immunoblastic Large Cell LymphomaAdult Lymphoblastic LymphomaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBreast CancerChronic Eosinophilic Leukemia
Start date
2011-02-01
Primary completion
2012-06-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.